J&J Taps Gorsky To Be Its Next CEO
This article was originally published in The Pink Sheet Daily
Executive Summary
Alex Gorsky was one of two internal candidates who had been vying for the position, which will become available as William Weldon yields the position on April 26.
You may also be interested in...
Sanofi Should Take Note: Insiders Might Just Make Better CEOs
As Sanofi looks for a replacement for Chris Viehbacher, it might want to take the recent track records of the CEOs at its competitors into consideration before making a decision.
J&J’s New Path Forward – An Interview With Alex Gorsky
In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience on both the device and pharma sides of the business, and opportunities for drug/device convergence.
J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track
The reorganization separates the U.S. OTC business - McNeil Consumer Healthcare - from the other consumer divisions "in order to give focused attention to quality and compliance, and the critical task of restoring" McNeil brands.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: